Evidence map›Paper›PMID 31667121›Full record

ArticleMethodsX2019

First indoor radon mapping and assessment excess lifetime cancer risk in Iran.

Samira Sherafat, Sepideh Nemati Mansour, Mohammad Mosaferi, Nayyereh Aminisani, Zabihollah Yousefi, Shahram Maleki

Abstract read
In one paragraph

Article in MethodsX, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samira SherafatHealth Faculty, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Sepideh Nemati MansourHealth Faculty, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad MosaferiHealth and Environment Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nayyereh AminisaniNoncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
Zabihollah YousefiDepartment of Environmental Health Engineering, Faculty of Health and Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Shahram MalekiMedical Geography, Ministry of Health, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radon (222Rn) is believed to be the main contributor to lung cancer second to smoking. The first national indoor radon map derived from some scattered regional radon surveys in Iran. The arithmetic mean of indoor radon concentration was calculated to 117.4 ± 97.7 Bq/m

Indexed as

Annual effective doseCR-39Excess lifetime cancer riskFloorIndoor radon mapping and health risk assessmentRadon map

Identifiers

PMID31667121
PMCPMC6812403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.